Aussie drug can starve cancer cells
The idea is to prevent the amino acid glutamine from entering the cancer cells, according to scientists from the University of Sydney and the Centenary Institute, whose research is focusing on melanoma.
Dr Jeff Holst (PhD), who heads the institute’s Origin of Cancer Research Group, said the new therapy works on the cancer cell’s normal biologic processes rather than on the cancer mutations.
“Our team has been looking at amino acid transporters — protein pumps — that sit on the surface of cells. We discovered back in 2008 that